DoMore Diagnostics secures EUR 10 million grant
In a great achievement, DoMore Diagnostics, a pioneering company in cancer diagnostics, and Oslo Cancer Cluster member has been awarded the prestigious EIC Accelerator grant totalling EUR 10 million – EUR 2.5 million in non-dilutive grant and EUR 7.5 million in equity matching.
One of Europe’s Leading Start-up Hubs
Oslo Cancer Cluster Incubator made the Financial Times Europe’s Leading Start-up Hubs list.
What does it take to make it?
What does it take to make it for new biotech companies?
Advancing Cancer Research in Norway: Eli Lilly’s SUNRAY-01 Study
Eli Lilly selected Norway as the site for its groundbreaking study project, despite the decline of the recent year’s number of clinical cancer trials.
Unique collaboration to build Nordic health industry
A new collaboration agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry.
A peak into Cancer Crosslinks
World-leading translational cancer research entered Oslo Cancer Cluster Innovation Park last week and created a buzz.